If the patient has a CD4 count of more than 350 cells/mm³, antiretroviral therapy is not yet needed. The need for antiretroviral treatment should be reassessed on completion of TB treatment.
If the patient has a history of WHO Stage 4 illness and/or a CD4 count of 200 -350 cells/mm³, complete 2 months of TB therapy before commencing ART.
If the patient has a CD4 count of less than 200 cells/mm³ or other serious HIV related illness, make sure that the patient is tolerating TB treatment before initiating ART. Patients in this group should be started on first-line therapy consisting of d4T/3TC/EFV.